Metraipolis › archive › dc_378e0da03e2e

Erythrocyte membrane-encapsulated SZF nanocomposites for hyperuricemia therapy — Europe PMC PMID:41646980

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41646980
DOI
10.3389/fimmu.2025.1695253
License (as archived)
solo-consultazione
Archived
2026-11-06T15:28:38.382Z
SHA-256 of the archived text
8236ed980f0ea57e76810711ec75ed7c1302860bcb898692f872b01bab0f60e1
Stable URL of this page
https://metraipolis.com/documento/dc_378e0da03e2e

How to cite

Erythrocyte membrane-encapsulated SZF nanocomposites for hyperuricemia therapy — Europe PMC PMID:41646980 — Europe PMC (en), https://europepmc.org/article/MED/41646980 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_378e0da03e2e (Metraipolis archive dc_378e0da03e2e, sha256 8236ed980f0ea57e76810711ec75ed7c1302860bcb898692f872b01bab0f60e1)
BibTeX
@misc{dc378e0da03e2e,
  title = {Erythrocyte membrane-encapsulated SZF nanocomposites for hyperuricemia therapy — Europe PMC PMID:41646980},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646980},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_378e0da03e2e; sha256 8236ed980f0ea57e76810711ec75ed7c1302860bcb898692f872b01bab0f60e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646980. Agents can read the archived copy with the MCP tool read_document.